Clinical Trial Update: A Long Term Follow-Up Study of Fabry Disease Subjects Treated With FLT190 [Phase 1, Phase 2]

View source ↗

Summary

A long-term follow-up study of FLT190 in Fabry disease subjects across Phase 1/2 has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• FLT190

Snippet

Sponsor: Spur Therapeutics | Conditions: Fabry Disease, Lysosomal Storage Diseases | Phase 1, Phase 2 | Status: COMPLETED